What is Johnson & Johnson's imbruvica — percent change (as a percent)?

Johnson & Johnson (JNJ) reported imbruvica — percent change (as a percent) of -28.4% in Q3 2025.

How has Johnson & Johnson's imbruvica — percent change (as a percent) changed year-over-year?

Johnson & Johnson's imbruvica — percent change (as a percent) decreased by 58.7% year-over-year, from -17.9% to -28.4%.

What does imbruvica — percent change (as a percent) mean?

The percentage growth or decline in sales for a specific drug compared to a previous period.

IMBRUVICA — Percent Change (as a percent)

Products & Services · Percent Change (as a percent)

Johnson & Johnson IMBRUVICA — Percent Change (as a percent) decreased by 125.4% to -28.4% in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 58.7%, from -17.9% to -28.4%. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ1 2018

Last reportedQ3 2025

How to read this metric

Positive growth indicates expanding market share or increased patient utilization, whereas negative growth suggests potential market share erosion, pricing pressure, or declining clinical relevance.

Detailed definition

This metric measures the period-over-period percentage growth or decline in net sales for a specific pharmaceutical prod...

Peer comparison

Comparable to product-level revenue growth rates reported by major pharmaceutical companies to track the performance of key growth drivers versus legacy products.

Metric ID: jnj_segment_imbruvica_percent_change_as_a_percent

Historical Data

14 periods

	Q2 '21	Q3 '21	Q4 '21	Q2 '22	Q3 '22	Q4 '22	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25
Value	25.3%	51.3%	7.8%	-26.2%	-42.5%	-43.8%	-64%	-39%	-13.7%	-24.3%	-17.9%	-29.5%	-12.6%	-28.4%
QoQ Change	—	+102.8%	-84.8%	-435.9%	-62.2%	-3.1%	-46.1%	+39.1%	+64.9%	-77.4%	+26.3%	-64.8%	+57.3%	-125.4%
YoY Change	—	—	—	-203.6%	-182.8%	-661.5%	-144.3%	+8.2%	—	+62.0%	+54.1%	-115.3%	+48.1%	-58.7%

Range-64% – 51.3%

CAGR+3.6%

Avg YoY Growth-119.4%

Median YoY Growth-87.0%

Similar Metrics at Other Companies

Eli LillyLLY View metric

Frequently Asked Questions

What is Johnson & Johnson's imbruvica — percent change (as a percent)?: Johnson & Johnson (JNJ) reported imbruvica — percent change (as a percent) of -28.4% in Q3 2025.
How has Johnson & Johnson's imbruvica — percent change (as a percent) changed year-over-year?: Johnson & Johnson's imbruvica — percent change (as a percent) decreased by 58.7% year-over-year, from -17.9% to -28.4%.
What does imbruvica — percent change (as a percent) mean?: The percentage growth or decline in sales for a specific drug compared to a previous period.